Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
talin 2 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
talin 2 As a major component of focal adhesion plaques that links integrin to the actin cytoskeleton, may play an important role in cell adhesion. Recruits PIP5K1C to focal adhesion plaques and strongly activates its kinase activity. Note: This description may include information from UniProtKB.
Protein type: Motility/polarity/chemotaxis; Cytoskeletal protein
Cellular Component: ruffle; focal adhesion; cytoplasm; plasma membrane; synapse; intercellular junction; fascia adherens; actin cytoskeleton
Molecular Function: protein binding; structural constituent of cytoskeleton; structural molecule activity; actin binding; insulin receptor binding
Biological Process: intercellular junction assembly; cytoskeletal anchoring; cell adhesion
Reference #:  Q9Y4G6 (UniProtKB)
Alt. Names/Synonyms: DKFZp451B1011; DKFZp686I0976; DKFZp686K0979; ILWEQ; KIAA0320; talin 2; Talin-2; TLN2
Gene Symbols: TLN2
Molecular weight: 271,613 Da
Basal Isoelectric point: 5.4  Predict pI for various phosphorylation states
Select Structure to View Below

talin 2

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  DISEASE  |  Source  |  InnateDB  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 48 Y28-p FEPSTAVyDACRVIR
0 13 Y49-p QTGQASDyGLFLSDE
0 5 T69-p IWLEAGRtLDyYMLR
0 22 Y72-p EAGRtLDyYMLRNGD
0 1 T144 EEKKEEGTGtLKKDR
0 3 T146-p KKEEGTGtLKKDRTL
0 1 T192 QGVDENETLLLRRKF
0 4 Y201-p LLRRKFFySDQNVDS
0 1 S307-p KYVKLARsLRtYGVs
0 1 T310-p KLARsLRtYGVsFFL
0 1 S314-p sLRtYGVsFFLVKEK
0 1 T336-p VPRLLGItKDsVMRV
0 1 K337 PRLLGItKDsVMRVD
0 2 S339-p LLGItKDsVMRVDEK
0 5 S428-p TMLEESVsPKKSTIL
0 1 S449 TGKAEHGSVALPAVM
0 2 S473-p FNVGSMPsPQQQVMV
0 1 S585 CAITTISSNLTEMSK
0 1 T588 TTISSNLTEMSKGVK
0 2 S623-p RTLAGAVsDLLKAVQ
0 1 T632-p LLKAVQPtsGEPRQt
0 1 S633-p LKAVQPtsGEPRQtV
0 1 T639-p tsGEPRQtVLTAAGS
0 1 S673-p RFQDVLMsLAKAVAN
0 1 K690 AMLVLKAKNVAQVAE
0 1 S1032 CAKNLATSLAELRTA
0 3 Y1118-p AAQGNEHyTGVAARE
0 1 S1505 TIVAKHTSALCNACR
0 4 K1543-u NSTANLVkTIKALDG
0 481 Y1665-p PGQRECDysIDGINR
0 12 S1666-p GQRECDysIDGINRC
0 1 T1793-p GNPKAQHtHDAITEA
0 1 K1838-a AIAEAMSkLDEGtPP
0 37 T1843-p MSkLDEGtPPEPKGT
0 3 Y1854-p PKGTFVDyQtTVVKY
0 1 T1856-p GTFVDyQtTVVKYSK
0 1 S2052 LAQAAQSSAATITQL
0 1 S2069 VVKLGAASLGSDDPE
0 1 T2077-p LGSDDPEtQVVLINA
0 1 S2128-p VMVTNVTsLLKTVKA
0 1 T2282-p KRVAGAVtELIQAAE
0 1 K2477-a NLVRAAQkAAFGkAD
0 1 K2477-m1 NLVRAAQkAAFGkAD
0 1 K2482-m1 AQkAAFGkADDDDVV
0 1 K2531 QIRQQQYKFLPTELR
  mouse

 
Y28-p FEPSTAVyDACRVIR
Y49 QTGQASDYGLFLSDE
T69 IWLEAGRTLDyYMLR
Y72-p EAGRTLDyYMLRNGD
T144-p EEKKEEGtGtLKKDR
T146-p KKEEGtGtLKKDRTL
T192-p QGVDENEtLLLRRKF
Y201 LLRRKFFYSDQNVDS
S307 KYVKLARSLRTYGVS
T310 KLARSLRTYGVSFFL
S314 SLRTYGVSFFLVKEK
T336 VPRLLGITkDSVMRV
K337-u PRLLGITkDSVMRVD
S339 LLGITkDSVMRVDEK
S428-p TMLEESVsPKKSTIL
S449-p TGKAEHGsVALPAVM
S473-p FNVGSMPsPQQQVMV
S585-p CAITTISsNLtEMSK
T588-p TTISsNLtEMSKGVK
S623-p RTLAGAVsDLLKAVQ
T632 LLKAVQPTSGEPRQT
S633 LKAVQPTSGEPRQTV
T639 TSGEPRQTVLTAAGS
S673 RFQDVLMSLAKAVAN
K690-u AMLVLKAkNVAQVAE
S1032-p CAKNLATsLAELRTA
Y1118-p AAQGNEHyTGVAARE
S1505-p TIVAKHTsALCNACR
K1543-u NSTANLVkTIKALDG
Y1665-p PGQRECDysIDGINR
S1666-p GQRECDysIDGINRC
T1793 GNPKAQHTHDAITEA
K1838 AIAEAMSKLDEGtPP
T1843-p MSKLDEGtPPEPKGT
Y1854 PKGTFVDYQTTVVKY
T1856 GTFVDYQTTVVKYSK
S2052-p LAQAAQSsAATITQL
S2069-p VVKLGAAsLGSNDPE
T2077 LGSNDPETQVVLINA
S2128 VMVTNVTSLLKTVKA
T2282 KRVAGAVTELIQAAE
K2477 NLVRAAQKAAFGKAD
K2477 NLVRAAQKAAFGKAD
K2482 AQKAAFGKADDDDVV
K2531-m1 QIRQQQYkFLPTELR
  rat

 
Y30-p FEPSTAVyDACRVIR
Y51-p QTGQASDyGLFLSDE
T71 IWLEAGRTLDYYMLR
Y74 EAGRTLDYYMLRNGD
T146 EEKKEEGTGTLRKDR
T148 KKEEGTGTLRKDRTL
T194 QGVDENETLLLRRKF
Y203 LLRRKFFYSDQNVDS
S309 KYVKLARSLRTYGVS
T312 KLARSLRTYGVSFFL
S316 SLRTYGVSFFLVKEK
T338 VPRLLGITKDSVMRV
K339 PRLLGITKDSVMRVD
S341 LLGITKDSVMRVDEK
S430 TMLEESVSPKKSTIL
S451 TGKAEHGSVALPAVM
S475 FNVGSMPSPQQQVMV
S587 CAITTISSNLTEMSK
T590 TTISSNLTEMSKGVK
S625 RTLAGAVSDLLKAVQ
T634 LLKAVQPTSGEPRQT
S635 LKAVQPTSGEPRQTV
T641 TSGEPRQTVLTAAGS
S675 RFQDVLMSLAKAVAN
K692 AMLVLKAKNVAQVAE
S1034 CAKNLATSLAELRTA
Y1120 AAQGNEHYTGVAARE
S1507 TIVAKHTSALCNACR
K1545 NSTANLVKTIKALDG
Y1667-p PGQRECDySIDGINR
S1668 GQRECDySIDGINRC
T1795 GNPKAQHTHDAITEA
K1840 AIAEAMSKLDEGtPP
T1845-p MSKLDEGtPPEPKGT
Y1856 PKGTFVDYQTTVVKY
T1858 GTFVDYQTTVVKYSK
S2054 LAQAAQSSAATITQL
S2071 VVKLGAASLGSNDPE
T2079 LGSNDPETQVVLINA
S2130 VMVTNVTSLLKTVKA
T2284 KRVAGAVTELIQAAE
K2479 NLVRAAQKAAFGKAD
K2479 NLVRAAQKAAFGKAD
K2484 AQKAAFGKADDDDVV
K2533 QIRQQQYKFLPTELR
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.